Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLG) Tax Provisions (2016 - 2017)

Bone Biologics (BBLG) has disclosed Tax Provisions for 2 consecutive years, with $1600.0 as the latest value for Q2 2017.

  • On a quarterly basis, Tax Provisions changed N/A to $1600.0 in Q2 2017 year-over-year; TTM through Dec 2017 was $2243.0, a 0.0% change, with the full-year FY2021 number at $1600.0, changed 0.0% from a year prior.
  • Tax Provisions was $1600.0 for Q2 2017 at Bone Biologics, up from -$367.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1600.0 in Q1 2016 to a low of -$367.0 in Q4 2016.